Sprint Bioscience has entered a research collaboration with the Experimental Drug Development Centre (EDDC) in Singapore regarding the therapeutic expansion of Sprint Bioscience’s MASH (metabolic dysfunction-associated steatohepatitis) programme based on STK25 into inflammatory diseases.
LÄS MER